Beijing Sun-Novo Pharmaceutical Research Co. Ltd.SSE: 688621

Announcement on Signing the Technology Development Agreement for STC008 Injection

Dec 25, 2025 · Issued by Beijing Sun-Novo Pharmaceutical Research Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Dec 25, 2025 · 5 pages · Chinese

On 6ix: 6ix.com/news/announcement-on-signing-the-technology-development-agreement-for-stc008-injection

Release

Announcement on Signing the Technology Development Agreement for STC008 Injection

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Beijing Sun-Novo Pharmaceutical Research Co. Ltd. on 6ix

Earlier from Beijing Sun-Novo Pharmaceutical Research

Announcement on Voluntary Disclosure of Co-Establishment of a Joint LaboratoryDec 17, 2025
Announcement on Resolutions of the 5th Extraordinary General Meeting in 2025Dec 13, 2025
Announcement on Progress in Cancellation of Sub-subsidiary Nanjing Novostream Pharmaceutical Technology Co., Ltd. and Related Party TransactionsDec 3, 2025
Notice on Convening the 5th Extraordinary General Meeting in 2025Nov 26, 2025
Announcement on Submission of Application Materials for the Purchase of Assets through the Issuance of Shares and Convertible Corporate Bonds and the Collection of Supporting Funds, and the Related Party Transactions to the Shanghai Stock Exchange for ReviewNov 20, 2025

Later from Beijing Sun-Novo Pharmaceutical Research

Announcement on Deferring the Reply to the "Inquiry Letter Regarding the Review of Beijing Sun-Novo Pharmaceutical Research Co.,Ltd.’s Share Issuance and Convertible Bond Issuance for Asset Acquisition and Raising of Supporting Funds, and Related Party Transaction"Dec 27, 2025
Announcement on Stock Repurchase, Shareholding Increase and Loan ExtensionJan 1
Announcement on Litigation Results of the CompanyJan 17
Announcement on Voluntary Disclosure on the Acceptance of Clinical Trial Application for ABA001 InjectionJan 22
Announcement on Terminating the Issuance of Shares and Convertible Corporate Bonds to Purchase Assets and Raising Supporting Funds and Related Party Transactions, and the Withdrawal of Application DocumentsJan 28

All Beijing Sun-Novo Pharmaceutical Research news releases

Follow Beijing Sun-Novo Pharmaceutical Research into a list and get an email when it puts out news.

Follow Beijing Sun-Novo Pharmaceutical Research